Cite
HARVARD Citation
Häge, A. et al. (2016). Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial. Trials. 17 (1), pp. 1-16. [Online].